Filing Details
- Accession Number:
- 0001209191-10-025073
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-04 13:00:00
- Reporting Period:
- 2010-04-30
- Filing Date:
- 2010-05-04
- Accepted Time:
- 2010-05-04 16:51:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204787 | Clive Meanwell | 8 Sylvan Way Parsippany NJ 07054 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-04-30 | 237,000 | $4.79 | 550,281 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-04-30 | 175,250 | $7.51 | 375,031 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-03 | 6,250 | $7.46 | 368,781 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to buy) | Disposition | 2010-04-30 | 237,000 | $0.00 | 237,000 | $4.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-05-15 | No | 4 | M | Direct |
Footnotes
- Dr. Meanwell sold 181,500 shares of common stock in aggregate to pay for the cashless exercise of 237,000 options (reported on Table II of this Form 4) and the federal and state taxes associated with such exercise. Dr. Meanwell is holding the remaining 55,500 shares of common stock resulting from the exercise. The options would have expired on May 15, 2010, in which event Dr. Meanwell would have lost the right to acquire the shares underlying the options.
- The range of prices for the transactions reported on this line is between $7.26 and $7.83 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Dr. Meanwell sold in aggregate 181,500 shares to pay for the cashless exercise of the 237,000 options as reported on Table II and federal and state taxes associated with such exercise and held the remaining 55,500 shares of common stock resulting from the exercise. The options were set to expire May 15, 2010.
- The range of prices for the transactions reported on this line is between $7.45 and $7.49 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- The option vested in 48 equal monthly installments beginning on June 15, 2000.
Billionaire Hedge Funds
